Argininosuccinate synthase 1 suppresses tumor progression through activation of PERK/eIF2α/ATF4/CHOP axis in hepatocellular carcinoma

被引：0
|
作者：
Sanghwa Kim
Minji Lee
Yeonhwa Song
Su-Yeon Lee
Inhee Choi
I-Seul Park
Jiho Kim
Jin-sun Kim
Kang mo Kim
Haeng Ran Seo
机构：
[1] Institut Pasteur Korea,Cancer Biology Research Laboratory
[2] Institut Pasteur Korea,Medicinal Chemistry
[3] Institut Pasteur Korea,Screening Discovery Platform
[4] Asan Liver Center,Department of Gastroenterology
[5] Asan Medical Center,undefined
[6] University of Ulsan College of Medicine,undefined
来源：
Journal of Experimental & Clinical Cancer Research | / 40卷
关键词：
Hepatocellular carcinoma (HCC); Argininosuccinate synthase 1(ASS1); Endoplasmic reticulum (ER) stress; Spheroids; C/EBP homologous protein (CHOP);
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] Microglia-derived IL-1β promoted neuronal apoptosis through ER stress-mediated signaling pathway PERK/eIF2α/ATF4/CHOP upon arsenic exposure
    Liu, Xudan
    Chen, Yao
    Wang, Huanhuan
    Wei, Yuting
    Yuan, Ye
    Zhou, Qianqian
    Fang, Fang
    Shi, Sainan
    Jiang, Xiaojing
    Dong, Yinqiao
    Li, Xin
    JOURNAL OF HAZARDOUS MATERIALS, 2021, 417
  • [32] Salubrinal Mediated Fetal Hemoglobin Induction through the eIF2α-ATF4 Signaling Pathway
    Lopez, Nicole Hope
    Li, Biaoru
    Zhu, Xingguo
    Pace, Betty S.
    BLOOD, 2020, 136
  • [33] Salubrinal Mediated Fetal Hemoglobin Induction through the eIF2α-ATF4 Signaling Pathway
    Lopez, Nicole Hope
    Li, Biaoru
    Makala, Levi
    Pace, Betty S.
    BLOOD, 2017, 130
  • [34] Sigma-1Rs are upregulated via PERK/eIF2α/ATF4 pathway and execute protective function in ER stress
    Mitsuda, Teruhiko
    Omi, Tsubasa
    Tanimukai, Hitoshi
    Sakagami, Yukako
    Tagami, Shinji
    Okochi, Masayasu
    Kudo, Takashi
    Takeda, Masatoshi
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2011, 415 (03) : 519 - 525
  • [35] Expression of PERK-eIF2α-ATF4 pathway signaling protein in the progression of hepatic fibrosis in rats
    Luo, Xin-Hua
    Han, Bing
    Chen, Qu
    Guo, Xiao-Ting
    Xie, Ru-Jia
    Yang, Ting
    Yang, Qin
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2018, 11 (07): : 3542 - 3550
  • [36] Knockdown of NUPR1 inhibits angiogenesis in lung cancer through IRE1/XBP1 and PERK/eIF2α/ATF4 signaling pathways
    Wang, Lihuai
    Wen, Jing
    Sun, Yinhui
    Yang, Xiao
    Ma, Yi
    Tian, Xuefei
    OPEN MEDICINE, 2023, 18 (01):
  • [37] Activation of the eIF2α-ATF4 Pathway by Chronic Paracetamol Treatment Is Prevented by Dietary Supplementation with Cysteine
    Carraro, Valerie
    Combaret, Lydie
    Coudy-Gandilhon, Cecile
    Parry, Laurent
    Averous, Julien
    Maurin, Anne-Catherine
    Jousse, Celine
    Voyard, Guillaume
    Fafournoux, Pierre
    Papet, Isabelle
    Bruhat, Alain
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (13)
  • [38] Insulin-like growth factor-1 reduces hyperoxia-induced lung inflammation and oxidative stress and inhibits cell apoptosis through PERK/eIF2α/ATF4/CHOP signaling
    Cui, Haixia
    Zhang, Shujian
    Wu, Zhengxie
    Xu, Chunhua
    Xu, Dongyuan
    Jin, Zhengyong
    EXPERIMENTAL LUNG RESEARCH, 2022, 48 (4-6) : 187 - 197
  • [39] NCOA3 coactivator is a transcriptional target of XBP1 and regulates PERK–eIF2α–ATF4 signalling in breast cancer
    A Gupta
    M M Hossain
    N Miller
    M Kerin
    G Callagy
    S Gupta
    Oncogene, 2016, 35 : 5860 - 5871
  • [40] Integrating network pharmacology and experimental models to examine the mechanisms of corosolic acid in preventing hepatocellular carcinoma progression through activation PERK-eIF2a-ATF4 signaling
    Tang, Feifeng
    Peng, Yingxiu
    Liu, Jingjin
    Gao, Wenhui
    Xu, Yanfeng
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2023, 396 (12) : 3671 - 3682
12345